GLP-1 Diabetes Treatment Drugs Market expansion in India Revenue from GLP-1 diabetes treatment drugs in India is expanding at a CAGR of 31.6%, supported by growing diabetes awareness, increasing healthcare accessibility, and expanding pharmaceutical manufacturing applications
Bundle & Save Discount applies automatically at checkout once your cart subtotal hits the tier
Niu B, Liao K, Zhou Y, Wen T, Quan G, Pan X, et al
What are the signs you need a B12 shot
Interestingly, the medications that may be the most effective at achieving the desired outcome can be the ones that are more likely to cause adverse effects
For example, Muayad et al compared 61,998 patients with diabetes using GLP-1 RAs with metformin users in the US Collaborative Network of the TriNetX EHR database to calculate the risk of developing ocular hypertension or primary open-angle glaucoma, requiring topical glaucoma medication, or requiring laser trabeculoplasty